Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity

C. Plasencia, G. Wolbink, C. L. M. Krieckaert, E. L. Kneepkens, S. Turk, T. Jurado, A. Martinez-Feito, V. Navarro-Compan, G. Bonilla, A. Villalba, D. Peiteado, L. Nuno, E. Martin-Mola, M. T. Nurmohamed, D. van der Kleij, T. Rispens, D. Pascual-Salcedo, A. Balsa

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)655-662
JournalClinical and Experimental Rheumatology
Volume34
Issue number4
Publication statusPublished - 2016

Cite this

Plasencia, C. ; Wolbink, G. ; Krieckaert, C. L. M. ; Kneepkens, E. L. ; Turk, S. ; Jurado, T. ; Martinez-Feito, A. ; Navarro-Compan, V. ; Bonilla, G. ; Villalba, A. ; Peiteado, D. ; Nuno, L. ; Martin-Mola, E. ; Nurmohamed, M. T. ; van der Kleij, D. ; Rispens, T. ; Pascual-Salcedo, D. ; Balsa, A. / Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity. In: Clinical and Experimental Rheumatology. 2016 ; Vol. 34, No. 4. pp. 655-662.
@article{b353a31beca34e95a630f805f1084743,
title = "Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity",
keywords = "rheumatoid arthritis, TNF inhibitors, treatment, clinical outcome, tapering strategy",
author = "C. Plasencia and G. Wolbink and Krieckaert, {C. L. M.} and Kneepkens, {E. L.} and S. Turk and T. Jurado and A. Martinez-Feito and V. Navarro-Compan and G. Bonilla and A. Villalba and D. Peiteado and L. Nuno and E. Martin-Mola and Nurmohamed, {M. T.} and {van der Kleij}, D. and T. Rispens and D. Pascual-Salcedo and A. Balsa",
year = "2016",
language = "English",
volume = "34",
pages = "655--662",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "4",

}

Plasencia, C, Wolbink, G, Krieckaert, CLM, Kneepkens, EL, Turk, S, Jurado, T, Martinez-Feito, A, Navarro-Compan, V, Bonilla, G, Villalba, A, Peiteado, D, Nuno, L, Martin-Mola, E, Nurmohamed, MT, van der Kleij, D, Rispens, T, Pascual-Salcedo, D & Balsa, A 2016, 'Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity' Clinical and Experimental Rheumatology, vol. 34, no. 4, pp. 655-662.

Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity. / Plasencia, C.; Wolbink, G.; Krieckaert, C. L. M.; Kneepkens, E. L.; Turk, S.; Jurado, T.; Martinez-Feito, A.; Navarro-Compan, V.; Bonilla, G.; Villalba, A.; Peiteado, D.; Nuno, L.; Martin-Mola, E.; Nurmohamed, M. T.; van der Kleij, D.; Rispens, T.; Pascual-Salcedo, D.; Balsa, A.

In: Clinical and Experimental Rheumatology, Vol. 34, No. 4, 2016, p. 655-662.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity

AU - Plasencia, C.

AU - Wolbink, G.

AU - Krieckaert, C. L. M.

AU - Kneepkens, E. L.

AU - Turk, S.

AU - Jurado, T.

AU - Martinez-Feito, A.

AU - Navarro-Compan, V.

AU - Bonilla, G.

AU - Villalba, A.

AU - Peiteado, D.

AU - Nuno, L.

AU - Martin-Mola, E.

AU - Nurmohamed, M. T.

AU - van der Kleij, D.

AU - Rispens, T.

AU - Pascual-Salcedo, D.

AU - Balsa, A.

PY - 2016

Y1 - 2016

KW - rheumatoid arthritis

KW - TNF inhibitors

KW - treatment

KW - clinical outcome

KW - tapering strategy

M3 - Article

VL - 34

SP - 655

EP - 662

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 4

ER -